Supplier audit checklist for peptide and API buyers in Asia

This is the practical checklist a buyer can use before onboarding a new Asia-based peptide or API supplier. The goal is to separate verified facts from sales claims before budget, timeline, and quality risk compound.

Use this when

You are qualifying a new supplier, placing a meaningful first PO, comparing two suppliers, or deciding whether document review alone is enough.

Request a Risk Screen General supplier checklist

1) Entity and contact checks

Legal entity name, address, website, and invoicing details line up across documents.
Email domain and signatory names are consistent with the supplier identity.
Sales contacts are not presenting one company while invoicing through another without explanation.

2) Manufacturer vs. trader risk

The supplier can clearly explain what is manufactured in-house versus outsourced.
Facility claims, product breadth, and turnaround times are plausible together.
Technical answers reflect real process familiarity, not generic brochure language.

3) Documentation review

COAs are batch-specific and internally consistent.
Dates, addresses, product names, units, and methods line up across the evidence pack.
Claimed certifications and quality-system language are specific enough to be meaningful.

4) GMP claim review

The GMP claim ties to a site, process, and legal entity, not just marketing copy.
The claim is relevant to the quoted material and intended buying use case.
If the claim matters to the purchase decision, there is enough evidence to justify relying on it.

5) Factory and operational signals

The claimed facility footprint is real and consistent with the product story.
Equipment, cleanliness, staff activity, and traceability signals support the representation.
If the order size is meaningful, the buyer knows whether on-site verification is warranted.

6) Testing escalation

You know what question the test is supposed to answer: identity, purity, contamination, or batch comparison.
The sample-to-lab workflow is controlled enough that the result is interpretable.
A single test result is not being treated as a substitute for broader supplier qualification.

7) Final procurement decision

The output of a real supplier audit is simple: proceed, pause, or verify deeper. If the supplier still depends on too many unsupported assumptions, the buyer should know that before a PO moves.

Need this run against a real supplier? Email ops@asiapeptideverification.com or use the risk screen form.